Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Parasite Immunol ; 34(10): 486-91, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22742527

RESUMO

For better efficiency in the establishment of American tegumentary leishmaniasis clinical cure, the World Health Organization suggests that the clinical criteria are supported by serologic data. The present study aims to investigate the dynamics of IgG subclass production in clinical evolution post-treatment of cutaneous leishmaniasis (CL). Paired sera from 23 subjects with CL resulting from Leishmania braziliensis infection were studied during the active lesion phase (aCL) and after clinical cure post-therapy (hCL), which included an alternative protocol with a low dose of antimony. Anti-Leishmania IgG and its subclasses were measured using ELISA, and the immunoglobulin levels were correlated with patients' clinical data. All of the subjects were clinically healed and did not present relapse during follow-up. Serum levels of anti-Leishmania IgG (r = -0·79; P < 0·0001), IgG1 (r = -0·64, P < 0·001) and IgG3 (r = -0·42, P < 0·045) in hCL were negatively correlated with the duration of clinical cure. After 24 months of clinical cure, 73% of samples were negative for IgG1 and 78% were negative for IgG3. In conclusion, the detection of serum anti-Leishmania IgG1 and IgG3 is an improved laboratory strategy to aid in the decision of interruption of the ambulatory follow-up of CL patients.


Assuntos
Anticorpos Antiprotozoários/sangue , Imunoglobulina G/sangue , Leishmania braziliensis/imunologia , Leishmania braziliensis/patogenicidade , Leishmaniose Cutânea/imunologia , Leishmaniose Cutânea/patologia , Adolescente , Adulto , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Leishmaniose Cutânea/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
2.
Immunobiology ; 216(3): 409-15, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20655616

RESUMO

Injury triggers inflammatory responses and tissue repair. Several treatments are currently in use to accelerate healing; however, more efficient formulations are still needed for specific injuries. Since unsaturated fatty acids modulate immune responses, we aimed to evaluate their therapeutic effects on wound healing. Skin wounds were induced in BALB/c mice and treated for 5 days with n-3, n-9 fatty acids or vehicle (control). n-9 treated mice presented smaller wounds than control and n-3 at 120 h post-surgery (p.s.). Collagen III mRNA, TIMP1 and MMP9 were significantly elevated in n-9 group compared to n-3 or vehicle at 120 h p.s. Among the inflammatory mediators studied we found that IL-10, TNF-α and IL-17 were also higher in n-9 treated group compared to n-3 or vehicle at 120 h p.s. Interestingly, COX2 had decreased expression on wound tissue treated with n-9. Inflammatory infiltrate analysis revealed diminished frequency of CD4(+), CD8(+) and CD11b(+) cells in n-9 wounds at 24 and 120 h p.s., which was not related to cell death, since in vitro apoptosis experiments did not show any cell damage after fatty acids administration. These results suggested that unsaturated fatty acids, specifically n-9, modulate the inflammation in the wound and enhance reparative response in vivo. n-9 may be a useful tool in the treatment of cutaneous wounds.


Assuntos
Ácidos Linolênicos/farmacologia , Ácido Oleico/farmacologia , Pele/imunologia , Pele/lesões , Cicatrização/efeitos dos fármacos , Cicatrização/imunologia , Animais , Apoptose , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/imunologia , Colágeno/genética , Ciclo-Oxigenase 2/genética , Citometria de Fluxo , Expressão Gênica , Inflamação , Interleucina-10/sangue , Interleucina-17/sangue , Ácidos Linolênicos/uso terapêutico , Macrófagos/imunologia , Metaloproteinase 9 da Matriz/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Ácido Oleico/uso terapêutico , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Pele/efeitos dos fármacos , Pele/crescimento & desenvolvimento , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Fator de Necrose Tumoral alfa/sangue
3.
Braz J Med Biol Res ; 33(3): 269-78, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10719377

RESUMO

Penetration of Trypanosoma cruzi into mammalian cells depends on the activation of the parasite's protein tyrosine kinase and on the increase in cytosolic Ca2+ concentration. We used metacyclic trypomastigotes, the T. cruzi developmental forms that initiate infection in mammalian hosts, to investigate the association of these two events and to identify the various components of the parasite signal transduction pathway involved in host cell invasion. We have found that i) both the protein tyrosine kinase activation, as measured by phosphorylation of a 175-kDa protein (p175), and Ca2+ mobilization were induced in the metacyclic forms by the HeLa cell extract but not by the extract of T. cruzi-resistant K562 cells; ii) treatment of parasites with the tyrosine kinase inhibitor genistein blocked both p175 phosphorylation and the increase in cytosolic Ca2+ concentration; iii) the recombinant protein J18, which contains the full-length sequence of gp82, a metacyclic stage surface glycoprotein involved in target cell invasion, interfered with tyrosine kinase and Ca2+ responses, whereas the monoclonal antibody 3F6 directed at gp82 induced parasite p175 phosphorylation and Ca2+ mobilization; iv) treatment of metacyclic forms with phospholipase C inhibitor U73122 blocked Ca2+ signaling and impaired the ability of the parasites to enter HeLa cells, and v) drugs such as heparin, a competitive IP3-receptor blocker, caffeine, which affects Ca2+ release from IP3-sensitive stores, in addition to thapsigargin, which depletes intracellular Ca2+ compartments and lithium ion, reduced the parasite infectivity. Taken together, these data suggest that protein tyrosine kinase, phospholipase C and IP3 are involved in the signaling cascade that is initiated on the parasite cell surface by gp82 and leads to Ca2+ mobilization required for target cell invasion.


Assuntos
Cálcio/metabolismo , Proteínas de Protozoários/metabolismo , Transdução de Sinais , Trypanosoma cruzi/fisiologia , Animais , Cálcio/análise , Ativação Enzimática , Células HeLa/parasitologia , Humanos , Células K562/parasitologia , Camundongos , Fosforilação , Proteínas Tirosina Quinases/metabolismo , Trypanosoma cruzi/efeitos dos fármacos , Fosfolipases Tipo C/metabolismo
4.
Infect Immun ; 67(9): 4908-11, 1999 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10456948

RESUMO

Peptides derived from the surface glycoprotein gp82 of Trypanosoma cruzi, previously implicated in the parasite's invasion of host cells, were expressed as fusions to the protein LamB of Escherichia coli in a region known to be exposed on the cell surface. Bacteria expressing these proteins adhered to HeLa cells in a manner that mimics the pattern of parasite invasion of mammalian cells. Purified LamB fusion proteins were shown to bind to HeLa cells and to inhibit infection by T. cruzi, supporting the notion that these gp82-derived peptides can mediate interaction of the parasite with its host.


Assuntos
Aderência Bacteriana/fisiologia , Proteínas da Membrana Bacteriana Externa/metabolismo , Escherichia coli/fisiologia , Glicoproteínas de Membrana/metabolismo , Proteínas de Protozoários/metabolismo , Receptores Virais/metabolismo , Trypanosoma cruzi , Sequência de Aminoácidos , Animais , Proteínas da Membrana Bacteriana Externa/genética , Expressão Gênica , Células HeLa , Humanos , Glicoproteínas de Membrana/genética , Dados de Sequência Molecular , Peptídeos/metabolismo , Porinas , Proteínas de Protozoários/genética , Receptores Virais/genética , Proteínas Recombinantes de Fusão/genética , Trypanosoma cruzi/patogenicidade
5.
Exp Parasitol ; 89(2): 188-94, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9635442

RESUMO

We examined the requirement of Tropanosoma cruzi protein tyrosine phosphorylation for parasite entry into mammalian cells and analyzed the profile of phosphorylated proteins in infective trypomastigotes. Treatment of metacyclic or tissue culture trypomastigotes with genistein, an inhibitor of protein tyrosine kinase activity, significantly inhibited invasion of cultured HeLa cells. A soluble factor, contained in HeLa cell extract and absent in the extract ot T. cruzi-resistant K562 cells, greatly enhanced phosphorylation levels of a 175-kDa protein (p175) in trypomastigotes. Genistein inhibited p175 tyrosine phosphorylation. P175 was undetectable in noninvasive epimastigotes. The phosphorylation-inducing activity of HeLa cell extract was abrogated by adsorption with metacyclic trypomastigotes but not with epimastigotes or when it was mixed with recombinant protein J18, which contains the entire peptide sequence of gp82, a metacyclic stage-specific surface glycoprotein implicated in target cell invasion. These data suggest that, in metacyclic trypomastigotes, gp82 is the signaling receptor that mediates protein tyrosine phosphorylation necessary for host cell invasion.


Assuntos
Células HeLa/parasitologia , Proteínas Tirosina Quinases/metabolismo , Proteínas de Protozoários/metabolismo , Trypanosoma cruzi/patogenicidade , Tirosina/metabolismo , Animais , Extratos Celulares/farmacologia , Linhagem Celular , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Genisteína/farmacologia , Células HeLa/química , Humanos , Camundongos , Fosforilação , Proteínas Tirosina Quinases/antagonistas & inibidores , Proteínas de Protozoários/química , Ratos , Transdução de Sinais , Trypanosoma cruzi/efeitos dos fármacos , Trypanosoma cruzi/metabolismo , Células Tumorais Cultivadas
6.
Biochem J ; 330 ( Pt 1): 505-11, 1998 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-9461549

RESUMO

Mammalian cell invasion assays, using metacyclic trypomastigotes of Trypanosoma cruzi G and CL strains, showed that the CL strain enters target cells in several-fold higher numbers as compared with the G strain. Analysis of expression of surface glycoproteins in metacyclic forms of the two strains by iodination, immunoprecipitation and FACS, revealed that gp90, undetectable in the CL strain, is one of the major surface molecules in the G strain, that expression of gp82 is comparable in both strains and that gp35/50 is expressed at lower levels in the CL strain. Purified gp90 and gp35/50 bound more efficiently than gp82 to cultured HeLa cells. However, the intensity of the Ca2+ response triggered in HeLa cells by gp82 was significantly higher than that induced by gp35/50 or gp90. Most of the Ca2+ signalling activity of the metacyclic extract towards HeLa cells was due to gp82 and was inhibitable by gp82-specific monoclonal antibody 3F6. Ca2+ mobilization was also triggered in metacyclic trypomastigotes by host-cell components; it was mainly gp82-mediated and more intense in the CL than in the G strain. We propose that expression of gp90 and gp35/50 at high levels impairs binding of metacyclic forms to host cells through productive gp82-mediated interaction, which leads to the target-cell and parasite Ca2+ mobilization required for invasion. Analysis of metacyclic forms of eight additional T. cruzi strains corroborated the inverse correlation between infectivity and expression of gp90 and gp35/50.


Assuntos
Cálcio/fisiologia , Proteínas de Protozoários/fisiologia , Trypanosoma cruzi/patogenicidade , Animais , Anticorpos Antiprotozoários/fisiologia , Antígenos de Protozoários/fisiologia , Antígenos de Superfície/fisiologia , Moléculas de Adesão Celular/fisiologia , Glicoproteínas/fisiologia , Peso Molecular , Proteínas de Protozoários/química , Glicoproteínas Variantes de Superfície de Trypanosoma/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...